0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......


Basic View | Expanded View
 Showing 1-16 of 16 Articles
Viewpoint  FREE
Donald M. Berwick, MD, MPP; Derek Feeley, DBA; Saranya Loehrer, MD, MPH
Includes: Supplemental Content
This Viewpoint discusses the need for leaders in health care to steer the next phase of health care reform.
Viewpoint  FREE
Scott M. Berry, PhD; Jason T. Connor, PhD; Roger J. Lewis, MD, PhD
Includes: Supplemental Content
This Viewpoint discusses the use of platform trials for efficient evaluation of multiple treatments.
Viewpoint  FREE
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
This Viewpoint discusses important questions about how to efficiently screen for hepatitis B virus (HBV) for those at risk of HBV reactivation.
Editorial  FREE
Matthew A. Cavender, MD, MPH; David P. Faxon, MD
Bivalirudin, a direct thrombin inhibitor, has been studied as an alternative to heparin for patients undergoing percutaneous coronary intervention (PCI) with stable coronary artery disease,1,2 non–ST-segment elevation acute coronary syndrome (NSTE-ACS),3,4 and ST-elevation myocardial infarction (STEMI).5,6 These studies found that bivalirudin reduced major bleeding when compared with regimens of heparin ...
Original Investigation  FREE
Yaling Han, MD, PhD; Jincheng Guo, MD; Yang Zheng, MD; Hongyun Zang, MD; Xi Su, MD; Yu Wang, MD; Shaoliang Chen, MD; Tiemin Jiang, MD; Ping Yang, MD; Jiyan Chen, MD; Dongju Jiang, MD; Quanmin Jing, MD; Zhenyang Liang, MBBS; Haiwei Liu, MD; Xin Zhao, MD; Jing Li, MBBS; Yi Li, MD; Bo Xu, MBBS; Gregg W. Stone, MD; for the BRIGHT Investigators
Includes: Supplemental Content

Importance  The safety and efficacy of bivalirudin compared with heparin with or without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI) are uncertain.

Objective  To determine if bivalirudin is superior to heparin alone and to heparin plus tirofiban ...

Editorial: Bivalirudin and Percutaneous Coronary Intervention; Matthew A. Cavender, MD, MPH; David P. Faxon, MD
Editorial  FREE
Meir Stampfer, MD, DrPH; Walter Willett, MD, DrPH
The effect of folate supplementation on cardiovascular disease has been studied in many observational studies and randomized trials and has been a topic of debate for a number of years. In this issue of JAMA, Huo and colleagues1 provide results from their important clinical trial of folic acid therapy for ...
Original Investigation  FREE
Yong Huo, MD; Jianping Li, MD, PhD; Xianhui Qin, PhD; Yining Huang, MD; Xiaobin Wang, MD, ScD; Rebecca F. Gottesman, MD, PhD; Genfu Tang, MD; Binyan Wang, MD, PhD; Dafang Chen, PhD; Mingli He, MD; Jia Fu, MD; Yefeng Cai, MD; Xiuli Shi, MD; Yan Zhang, MD, PhD; Yimin Cui, MD, PhD; Ningling Sun, MD; Xiaoying Li, MD; Xiaoshu Cheng, MD; Jian’an Wang, MD; Xinchun Yang, MD; Tianlun Yang, MD; Chuanshi Xiao, MD; Gang Zhao, MD; Qiang Dong, MD; Dingliang Zhu, MD; Xian Wang, MD, PhD; Junbo Ge, MD; Lianyou Zhao, MD; Dayi Hu, MD; Lisheng Liu, MD; Fan Fan Hou, MD, PhD; for the CSPPT Investigators
Includes: Supplemental Content

Importance  Uncertainty remains about the efficacy of folic acid therapy for the primary prevention of stroke because of limited and inconsistent data.

Objective  To test the primary hypothesis that therapy with enalapril and folic acid is more effective in reducing first stroke than enalapril alone among ...

Editorial: Folate Supplements for Stroke Prevention; Meir Stampfer, MD, DrPH; Walter Willett, MD, DrPH
Viewpoint  FREE
Michelle Rodriguez, JD; Jason Morrow, MD, PhD; Ali Seifi, MD
This Viewpoint considers the possibility that patients and families may secretly record their visits with physicians and discusses how to manage such a possibility so as not to undermine patient-physician relationships.
Viewpoint  FREE
Stephen A. Martin, MD, EdM; Kenn Harris; Brian W. Jack, MD
Includes: Supplemental Content
This Viewpoint discusses reimagining and repurposing efforts in American health care for the benefit of marginalized communities.
Editorial: Race, Poverty, and Medicine in the United States; Howard Bauchner, MD
Viewpoint  FREE
Winston F. Wong, MD, MS; Thomas A. LaVeist, PhD; Joshua M. Sharfstein, MD
This Viewpoint discusses motivating health care organizations to consider a new set of tools and approaches to disparities in health outcomes by race/ethnicity and income status such as payment systems that reward better outcomes and building equity into program design.
Editorial: Race, Poverty, and Medicine in the United States; Howard Bauchner, MD
Editorial  FREE
Howard Bauchner, MD
I spent most of my career at the Boston City Hospital, now known as Boston Medical Center, that has emphasized “exceptional care without exception.” At Boston City Hospital the 2 worlds of race and poverty collide on an almost daily basis. Under the 4-decade leadership of 2 pediatric chairs, Joel ...
Viewpoint  FREE
Lauren S. Hughes, MD, MPH; Alon Peltz, MD, MBA; Patrick H. Conway, MD, MSc
Includes: Supplemental Content
This Viewpoint describes the State Innovation Model initiative, including innovations states have made for health care delivery systems as well as lessons learned.
Viewpoint  FREE
JoAnn E. Manson, MD, DrPH; Shari S. Bassuk, ScD
This Viewpoint discusses vitamin D screening and supplemental vitamin D for nonskeletal health benefits in light of existing recommendations and large-scale trials in progress.
JAMA Patient Page  FREE
Jill Jin, MD, MPH
Measles is a very contagious and serious disease. It is also very preventable.
Topics: measles
Viewpoint 
Allan M. Joseph, BA; Eli Y. Adashi, MD, MS
This Viewpoint discusses tenets of the Consumer Operated and Oriented Plan program and challenges related to its implementation.
Viewpoint 
George A. Gellert, MD, MPH, MPA; Ricardo Ramirez, LVN; S. Luke Webster, MD
Includes: Supplemental Content
This Viewpoint argues that the increasing use of medical scribers to record patient data will impede the development of electronic health record management systems.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts